Skip to content

Drug interactions

Momelotinib + Telmisartan-amlodipine

Severity: Minor

Momelotinib and Telmisartan-amlodipine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Momelotinib is an OATP1B1/1B3 substrate, and telmisartan has been reported to inhibit these transporters. Higher momelotinib exposure could increase its adverse effects, although the clinical significance is uncertain.

What this interaction means in plain words

Momelotinib and Telmisartan-amlodipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Momelotinib belongs to Oncology; Telmisartan-amlodipine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible inhibition of OATP1B1/1B3-mediated hepatic uptake of momelotinib by telmisartan.

What to do

No dose change is generally required. Monitor for momelotinib adverse effects such as cytopenias, neuropathy and hypotension, especially at treatment start.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Momelotinib and Telmisartan-amlodipine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Momelotinib with Telmisartan-amlodipine?

MediHelp rates the interaction as minor. Momelotinib and Telmisartan-amlodipine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Momelotinib is an OATP1B1/1B3 substrate, and telmisartan has been reported to inhibit these transporters. Higher momelotinib exposure could increase its adverse effects, although the clinical significance is uncertain.

How serious is the interaction between Momelotinib and Telmisartan-amlodipine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is generally required. Monitor for momelotinib adverse effects such as cytopenias, neuropathy and hypotension, especially at treatment start.

What other medicines interact with Telmisartan-amlodipine?

MediHelp also lists interactions of Telmisartan-amlodipine with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Telmisartan-amlodipine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in